Request for Covid-19 Impact Assessment of this Report
Production, means the output of Polypeptide Drug
Revenue, means the sales value of Polypeptide Drug
This report studies Polypeptide Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Polypeptide Drug in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Polypeptide Drug in each application, can be divided into
Application 1
Application 2
Application 3
Global Polypeptide Drug Market Research Report 2016
1 Polypeptide Drug Market Overview
1.1 Product Overview and Scope of Polypeptide Drug
1.2 Polypeptide Drug Segment by Type
1.2.1 Global Production Market Share of Polypeptide Drug by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Polypeptide Drug Segment by Application
1.3.1 Polypeptide Drug Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Polypeptide Drug Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Polypeptide Drug (2011-2021)
2 Global Polypeptide Drug Market Competition by Manufacturers
2.1 Global Polypeptide Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Polypeptide Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Polypeptide Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Polypeptide Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Polypeptide Drug Market Competitive Situation and Trends
2.5.1 Polypeptide Drug Market Concentration Rate
2.5.2 Polypeptide Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Polypeptide Drug Production, Revenue (Value) by Region (2011-2016)
3.1 Global Polypeptide Drug Production and Market Share by Region (2011-2016)
3.2 Global Polypeptide Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Polypeptide Drug Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Polypeptide Drug Consumption by Regions (2011-2016)
4.2 North America Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Polypeptide Drug Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Polypeptide Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Polypeptide Drug Production and Market Share by Type (2011-2016)
5.2 Global Polypeptide Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Polypeptide Drug Price by Type (2011-2016)
5.4 Global Polypeptide Drug Production Growth by Type (2011-2016)
6 Global Polypeptide Drug Market Analysis by Application
6.1 Global Polypeptide Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Polypeptide Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Polypeptide Drug Manufacturers Profiles/Analysis
7.1 Novartis
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Polypeptide Drug Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Novartis Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Merck Serono
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Polypeptide Drug Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Merck Serono Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Ferring Pharmaceuticals
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Polypeptide Drug Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Ferring Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Ipsen PHarma Biotech
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Polypeptide Drug Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Ipsen PHarma Biotech Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Lilly
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Polypeptide Drug Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Lilly Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Asahi Kasei
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Polypeptide Drug Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Asahi Kasei Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 AstraZeneca
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Polypeptide Drug Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 AstraZeneca Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 SciClone Pharmaceuticals
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Polypeptide Drug Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 SciClone Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Takeda
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Polypeptide Drug Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Takeda Polypeptide Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
8 Polypeptide Drug Manufacturing Cost Analysis
8.1 Polypeptide Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Polypeptide Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Polypeptide Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Polypeptide Drug Market Forecast (2016-2021)
12.1 Global Polypeptide Drug Production, Revenue Forecast (2016-2021)
12.2 Global Polypeptide Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Polypeptide Drug Production Forecast by Type (2016-2021)
12.4 Global Polypeptide Drug Consumption Forecast by Application (2016-2021)
12.5 Polypeptide Drug Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Polypeptide Drug
Figure Global Production Market Share of Polypeptide Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Polypeptide Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Polypeptide Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Polypeptide Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Polypeptide Drug Production of Key Manufacturers (2015 and 2016)
Table Global Polypeptide Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Polypeptide Drug Production Share by Manufacturers
Figure 2016 Polypeptide Drug Production Share by Manufacturers
Table Global Polypeptide Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Polypeptide Drug Revenue Share by Manufacturers
Table 2016 Global Polypeptide Drug Revenue Share by Manufacturers
Table Global Market Polypeptide Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Polypeptide Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Polypeptide Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Polypeptide Drug Product Type
Figure Polypeptide Drug Market Share of Top 3 Manufacturers
Figure Polypeptide Drug Market Share of Top 5 Manufacturers
Table Global Polypeptide Drug Production by Regions (2011-2016)
Figure Global Polypeptide Drug Production and Market Share by Regions (2011-2016)
Figure Global Polypeptide Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Polypeptide Drug Production Market Share by Regions
Table Global Polypeptide Drug Revenue by Regions (2011-2016)
Table Global Polypeptide Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Polypeptide Drug Revenue Market Share by Regions
Table Global Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Polypeptide Drug Consumption Market by Regions (2011-2016)
Table Global Polypeptide Drug Consumption Market Share by Regions (2011-2016)
Figure Global Polypeptide Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Polypeptide Drug Consumption Market Share by Regions
Table North America Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table China Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table India Polypeptide Drug Production, Consumption, Import & Export (2011-2016)
Table Global Polypeptide Drug Production by Type (2011-2016)
Table Global Polypeptide Drug Production Share by Type (2011-2016)
Figure Production Market Share of Polypeptide Drug by Type (2011-2016)
Figure 2015 Production Market Share of Polypeptide Drug by Type
Table Global Polypeptide Drug Revenue by Type (2011-2016)
Table Global Polypeptide Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Polypeptide Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Polypeptide Drug by Type
Table Global Polypeptide Drug Price by Type (2011-2016)
Figure Global Polypeptide Drug Production Growth by Type (2011-2016)
Table Global Polypeptide Drug Consumption by Application (2011-2016)
Table Global Polypeptide Drug Consumption Market Share by Application (2011-2016)
Figure Global Polypeptide Drug Consumption Market Share by Application in 2015
Table Global Polypeptide Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Polypeptide Drug Consumption Growth Rate by Application (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Polypeptide Drug Market Share (2011-2016)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Serono Polypeptide Drug Market Share (2011-2016)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ferring Pharmaceuticals Polypeptide Drug Market Share (2011-2016)
Table Ipsen PHarma Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen PHarma Biotech Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ipsen PHarma Biotech Polypeptide Drug Market Share (2011-2016)
Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lilly Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lilly Polypeptide Drug Market Share (2011-2016)
Table Asahi Kasei Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Asahi Kasei Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Asahi Kasei Polypeptide Drug Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Polypeptide Drug Market Share (2011-2016)
Table SciClone Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SciClone Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure SciClone Pharmaceuticals Polypeptide Drug Market Share (2011-2016)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Polypeptide Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Polypeptide Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Global Polypeptide Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Polypeptide Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Polypeptide Drug Production Forecast by Regions (2016-2021)
Table Global Polypeptide Drug Consumption Forecast by Regions (2016-2021)
Table Global Polypeptide Drug Production Forecast by Type (2016-2021)
Table Global Polypeptide Drug Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...